4295 articles
OGI Eyewear’s spring 2022 release includes new collections for Red Rose, Seraphin and Seraphin Shimmer. The latter brings pops of jewel colourways to its existing roster and also features a capsule release of limited-edition sunglasses – a first for the brand!
Etnia Barcelona is starting 2022 with a bang, creating The Etnia Eyewear Culture Group and launching three new independent brands – Allpoets, The Readers, and Lool.
Best known for his previous role as Alcon’s long-term sales manager of the New Zealand vision care team, Wellingtonian (and die-hard Hurricanes fan) Roger Te Puni has returned to the eyecare world, joining optical lens manufacturer CR Surfacing.
A large-scale US review has revealed an increased risk of visual impairment among users of e-cigarettes (vapers).
Dutz’s latest collection brings some much-needed fun and colour, featuring retro models with a funky revamped twist. The rounded DZ819 style featured here offers a neo-vintage update with beautiful, rounded-oval shapes in summery metallics.
US-based digital lens design company QLDS has developed Omnilux, a novel, natural accommodation multifocal spectacle lens the company says requires no fitting-height measurement or adaptation period.
Danish brand Bellinger is moving away from neutrals, showcasing a new collection featuring more vibrant colours and bold patterns.
US researchers have formally linked Covid-19 infection with a recent surge in mucormycosis, also known as ‘black fungus’ and formerly considered a rare disease. Led by ophthalmologist Dr Andrea
An Australian and US study has found that, compared to in-depth annual reviews, less stringent six-monthly reviews of glaucoma suspects resulted in more diagnoses, fewer overall clinical visits and
A US trial has shown a bioengineered stem-cell-derived retinal implant produced donor cells two years after implantation in a patient with advanced dry age-related macular degeneration (AMD), despite
A first-of-its-kind artificial vision system has successfully been implanted, providing the possibility of restoring partial vision to people with sight loss due to eye disease or trauma. The
A Johns Hopkins Medicine study of 106 patients with wet (neovascular) age-related macular degeneration (nAMD) has found a third of patients could cease intravitreal (IVT) injections without further vision loss.